Perhaps I spoke too soon when I complained about the trickle of "new news" regarding HIV and AIDS in the U.S. Reuters has a story out today about the waiting lists for some state ADAP programs thanks to a new study (PDF) released by the Kaiser Family Foundation. The Reuters report is, however, much truncated from the much more informative press release issued by the Foundation about the study.
Texas is shown in the report as providing "all approved ARV's in all four drug classes, NRTIs, NNRTIs, PIs, and Fuseon Inhibitor" but "[less than] 10 'AI' drugs recommended for the prevention of OIs." The PowerPoint presentation for the report does not show that Texas has a waiting list for the Fuseon Inhibitor, and that number (now about 36) is not apparently included in the total number of persons counted as being on waiting lists for ADAPs. Texas is listed as one of the states with cost containment measures in place and anticipation of additional measures needed in FY 2005.
KFF also provides a brief fact sheet (PDF) on the issue (with some clue about all those acronyms I threw out above).